Physician

Harvinder Singh, MD

According to 2025 Medicare claims, Harvinder Singh, MD (NPI: 1043267354) practices hematology/oncology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Anne Arundel, MD. This provider's primary affiliated billing organization is UNIVERSITY OF MARYLAND COMMUNITY MEDICAL GROUP, INC. (NPI: 1477530624; TIN: 521874111) and primary practice location at 21061-5805.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 551 traditional Medicare patients, billed 294,065 HCPCS/CPT codes, and received $5,353,321 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 735 prescription claims across 188 beneficiaries totaling $1,724,880 in drug costs, led by Brukinsa (Zanubrutinib). 2023 DME data shows 49 claims. Open Payments data shows 48 records totaling $1,300. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,967,401 to $5,353,321. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $797,014 to $1,724,880. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $13,912 and ending at $442.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.7M$5.4M2015 Medicare payment: $1,967,401 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,896,097 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,779,956 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,284,964 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,198,981 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,503,918 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,790,728 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,830,732 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,845,845 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,353,321 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015458182,460$1,967,401
2016437206,263$1,896,097
2017531248,619$2,779,956
2018525281,222$3,284,964
2019538251,438$3,198,981
2020563266,293$3,503,918
2021445267,365$4,790,728
2022530335,782$4,830,732
2023556288,194$4,845,845
2024551294,065$5,353,321

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.6M2015 Drug cost: $797,014 (USD; Tot_Drug_Cst)2016 Drug cost: $866,059 (USD; Tot_Drug_Cst)2017 Drug cost: $974,787 (USD; Tot_Drug_Cst)2018 Drug cost: $1,137,245 (USD; Tot_Drug_Cst)2019 Drug cost: $1,975,777 (USD; Tot_Drug_Cst)2020 Drug cost: $2,550,930 (USD; Tot_Drug_Cst)2021 Drug cost: $2,034,527 (USD; Tot_Drug_Cst)2022 Drug cost: $2,377,089 (USD; Tot_Drug_Cst)2023 Drug cost: $2,140,802 (USD; Tot_Drug_Cst)2024 Drug cost: $1,724,880 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151311,048$797,014
20161571,203$866,059
20171781,252$974,787
20181951,521$1,137,245
20192031,542$1,975,777
20201951,505$2,550,930
20212131,581$2,034,527
20222321,679$2,377,089
20232301,301$2,140,802
2024188735$1,724,880

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$20K$40K2015 Medicare payment: $39,981 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $38,366 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $12,223 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $11,007 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,815 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,881 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $8,041 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $6,193 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $2,281 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R186$39,981
2016N/R90$38,366
2017N/R52$12,223
2018N/R142$11,007
2019N/R75$5,815
2020N/R22$1,881
2021N/R114$8,041
2022N/R107$6,193
2023N/R49$2,281
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes124149$141
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more4311,236$140
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes130610$97
96372Injection of drug or substance under skin or into muscle134917$11
36415Insertion of needle into vein for collection of blood sample241755$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib19570$260,581
CabometyxCabozantinib S-Malate11316$203,317
XtandiEnzalutamide17510$199,116
KisqaliRibociclib Succinate11308$186,508
EliquisApixaban472,190$42,274

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.48$1,300Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Harvinder Singh, MD?

Tedicare shows public-source Medicare data for Harvinder Singh, MD (NPI 1043267354), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harvinder Singh, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Harvinder Singh, MD?

Harvinder Singh, MD is linked to UNIVERSITY OF MARYLAND COMMUNITY MEDICAL GROUP, INC. (billing NPI 1477530624) in the available physician profile data.

Does Harvinder Singh, MD have Open Payments data?

Harvinder Singh, MD has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.